Cryosite is a highly experienced, trusted and certified Australian depot partner in biological storage and clinical trial logistics. Cryosite partners with clients across the globe including: pharmaceutical sponsors and manufacturers, CROs and CMOs, research institutes and biotechnology industries. Services include specialist temperature-controlled storage, sourcing, labelling, status management, secondary packaging, schedule drug distribution, destruction, returns and biorepository services. Cryosite operates a fully regulated GMP/GWP facility and leads the market in providing tailored eco-friendly reusable packaging solutions. Cryosite has been listed on the Australia Stock Exchange (ASX: CTE) since 2002.
|
|
|
11-50 employees
View all Cryosite Limited employees
|
|
Logistics & Supply Chain
|
|
13a Ferndell St, South Granville, NSW 2142, AU
|
|
1999
|
|
Biorepository, Clinical Trials, Certified Destruction, Environmental Monitoring, Liquid Nitrogen, Gmp Certified, Secondary Packaging, Clinical Trial Logistics, Cold Chain, Biological Storage, Ambient Storage, Logistics Depot, Ultra-Low Temperature, Cold & Frozen Storage, Biological Logistics, Controlled Drug Storage Capabilities, Scheduled Medicine Distribution, Secure Monitored Facility, Tga Licensed Facility, Temperature Conrolled Storage And Shipping, 24H Temperature Monitoring & Alarms, Electronic Inven
|
Andrew Shine is the CEO of Cryosite Limited. To contact Andrew Shine email at [email protected]. Or you may call 0459871854 or +61.0414616111
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.